FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

37688711000001107: Betamethasone valerate 0.1% / Clioquinol 3% cream (CST Pharma Ltd) 30 gram (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Oct 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
416491000001112 Betamethasone valerate 0.1% / Clioquinol 3% cream (CST Pharma Ltd) 30 gram en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
416501000001115 Betamethasone valerate 0.1% / Clioquinol 3% cream (CST Pharma Ltd) 30 gram (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Betamethasone valerate 0.1% / Clioquinol 3% cream (CST Pharma Ltd) 30 gram Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Betamethasone valerate 0.1% / Clioquinol 3% cream (CST Pharma Ltd) 30 gram Is a Clioquinol 3% / Betamethasone valerate 0.1% cream 30 gram true Inferred relationship Existential restriction modifier
Betamethasone valerate 0.1% / Clioquinol 3% cream (CST Pharma Ltd) 30 gram Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Betamethasone valerate 0.1% / Clioquinol 3% cream (CST Pharma Ltd) 30 gram Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Betamethasone valerate 0.1% / Clioquinol 3% cream (CST Pharma Ltd) 30 gram Has AMP Betamethasone valerate 0.1% / Clioquinol 3% cream (CST Pharma Ltd) true Inferred relationship Existential restriction modifier
Betamethasone valerate 0.1% / Clioquinol 3% cream (CST Pharma Ltd) 30 gram Has specific active ingredient Betamethasone valerate true Inferred relationship Existential restriction modifier
Betamethasone valerate 0.1% / Clioquinol 3% cream (CST Pharma Ltd) 30 gram Has dispensed dose form Cream true Inferred relationship Existential restriction modifier
Betamethasone valerate 0.1% / Clioquinol 3% cream (CST Pharma Ltd) 30 gram Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Betamethasone true Inferred relationship Existential restriction modifier
Betamethasone valerate 0.1% / Clioquinol 3% cream (CST Pharma Ltd) 30 gram VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Betamethasone valerate 0.1% / Clioquinol 3% cream (CST Pharma Ltd) 30 gram VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Betamethasone valerate 0.1% / Clioquinol 3% cream (CST Pharma Ltd) 30 gram Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Betamethasone valerate 0.1% / Clioquinol 3% cream (CST Pharma Ltd) 30 gram Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Betamethasone valerate 0.1% / Clioquinol 3% cream (CST Pharma Ltd) 30 gram Has specific active ingredient Clioquinol true Inferred relationship Existential restriction modifier
Betamethasone valerate 0.1% / Clioquinol 3% cream (CST Pharma Ltd) 30 gram Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Betamethasone valerate 0.1% / Clioquinol 3% cream (CST Pharma Ltd) 30 gram Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start